Top list · Worldwide
Oncology startups worldwide
334 oncology startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $12B between them, with the United States the most common home.
- 1
Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.
Founded 2011Cambridge, United States$1.4Blast round Jun 2022 - 2
ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.Erasca is a developer of oncology drugs intended to provide precision oncology options.
Founded 2018San Diego, United States$739Mlast round Jul 2026 - 3
Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Founded 2018New York, United States$675Mlast round Jun 2026 - 4
IDEAYA BiosciencesIDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Founded 2015South San Francisco, United States$608Mlast round Jun 2026 - 5
Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Founded 2018Carlsbad, United States$600Mlast round Sept 2026 - 6
Legend BiotechLegend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Founded 2015Piscataway, United States$576Mlast round Jun 2026 - 7
Enliven TherapeuticsEnliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Founded 2019Boulder, United States$460Mlast round Jun 2026 - 8
21st Century Oncology21st Century Oncology is a medical care center that offers cancer care services.21st Century Oncology is a medical care center that offers cancer care services.
Founded 1983Fort Myers, United States$325Mlast round Sept 2014 - 9
Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Founded 2010Redwood City, United States$299Mlast round Feb 2026 - 10
Repare TherapeuticsRepare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Founded 2016Saint Laurent, Canada$252Mlast round Oct 2021 - 11
Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Founded 2021Boston, United States$238Mlast round May 2026 - 12
CG OncologyCG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Founded 2010Irvine, United States$238Mlast round Dec 2024 - 13
InventisBioInventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA.InventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA.
Founded 2013Shanghai, China$236Mlast round Sept 2020 - 14
Solstice OncologySolstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Founded -Boston, United States$225Mlast round Sept 2026 - 15
Thyme CareThyme Care is an oncology care management company based in Nashville, Tennessee, founded in 2020 by Robin Shah and Bobby Green.Thyme Care is an oncology care management company based in Nashville, Tennessee, founded in 2020 by Robin Shah and Bobby Green.
Founded 2020Nashville, United States$222Mlast round Sept 2026 - 16
Kura OncologyKura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Founded 2014La Jolla, United States$210Mlast round Jan 2024 - 17
BostonGeneBostonGene is a biotechnology company based in Waltham, Massachusetts, founded in 2015.BostonGene is a biotechnology company based in Waltham, Massachusetts, founded in 2015.
Founded 2015Waltham, United States$200Mlast round Apr 2022 - 18
X4 PharmaceuticalsX4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Founded 2012Cambridge, United States$193Mlast round Oct 2025 - 19
NouscomNouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities in Rome, Italy.Nouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities in Rome, Italy.
Founded 2015Basel, Switzerland$191Mlast round Oct 2026 - 20
Harbour BioMedHarbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
Founded -China$190Mlast round Mar 2025 - 21
Cartesian TherapeuticsPioneering Potent, Safer Cell Therapy in and Beyond OncologyPioneering Potent, Safer Cell Therapy in and Beyond Oncology
Founded 2016Gaithersburg, United States$180Mlast round May 2026 - 22
Antares TherapeuticsAntares Therapeutics, Inc.Antares Therapeutics, Inc.
Founded -Boston, United States$177Mlast round May 2025 - 23
Aktis OncologyAktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
Founded 2021Boston, United States$175Mlast round Sept 2024 - 24
Mariana OncologyMariana Oncology is a biotechnology research industry.Mariana Oncology is a biotechnology research industry.
Founded 2021Watertown, United States$175Mlast round Sept 2023 - 25
Alpha-9 OncologyAlpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer.Alpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer.
Founded 2019Boston, Canada$175Mlast round Oct 2024 - 26Alphamab OncologyFounded -China$160Mlast round May 2019
- 27
Cerulean PharmaCerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Founded 2006San Diego, United States$152Mlast round Apr 2015 - 28
Scorpion TherapeuticsScorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology.Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology.
Founded 2020Boston, United States$150Mlast round Jul 2024 - 29
MOMA TherapeuticsMOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.
Founded 2020Cambridge, United States$150Mlast round May 2022 - 30
Clasp TherapeuticsClasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology.Clasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology.
Founded 2020Baltimore, United States$150Mlast round Mar 2024 - 31Cullinan OncologyFounded -United States$150Mlast round Oct 2017
- 32
ConcertAIConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.ConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.
Founded 2018Cambridge, United States$150Mlast round Mar 2022 - 33
MonoparMonopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Founded 2014Wilmette, United States$147Mlast round Sept 2025 - 34
Kolltan PharmaceuticalsKolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Founded 2007New Haven, United States$146Mlast round Mar 2014 - 35
Boundless BioBoundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Founded 2018La Jolla, United States$146Mlast round May 2023 - 36
Abdera TherapeuticsAbdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.Abdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.
Founded 2020South San Francisco, Canada$142Mlast round Apr 2023 - 37
Avistone PharmaceuticalsAvistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Founded 2011China$141Mlast round Dec 2023 - 38
Caribou BiosciencesCaribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Founded 2011Berkeley, United States$139Mlast round Jul 2023 - 39
Ellipses PharmaEllipses Pharma is a London-based oncology-focused drug development company that aims to accelerate the discovery and clinical advancement of innovative cancer medicines.Ellipses Pharma is a London-based oncology-focused drug development company that aims to accelerate the discovery and clinical advancement of innovative cancer medicines.
Founded 2015London, United Kingdom$136Mlast round Dec 2025 - 40
Innate PharmaInnate Pharma S.A.Innate Pharma S.A.
Founded 1999Marseille, France$134Mlast round Jun 2014 - 41
Acrivon TherapeuticsAcrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Founded 2018Cambridge, United States$130Mlast round Apr 2024 - 42
GalvanizeGalvanize Therapeutics is a commercial-stage medical technology company based in San Carlos, California.Galvanize Therapeutics is a commercial-stage medical technology company based in San Carlos, California.
Founded 2015Redwood City, United States$125Mlast round Jan 2019 - 432seventy bio2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Founded 2021Cambridge, United States$125Mlast round Feb 2023 - 44
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.Flare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.
Founded 2021Cambridge, United States$123Mlast round Mar 2023 - 45
Nexo TherapeuticsNexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncology and for challenging diseNexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncology and for challenging dise
Founded 2022Watertown, United States$120Mlast round Mar 2026 - 46
Virogin BiotechVirogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.Virogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.
Founded 2015Richmond, Canada$120Mlast round Sept 2021 - 47
MicrobioticaMicrobiotica is a clinical-stage biopharmaceutical company based in Cambridge, UK, founded in 2016.Microbiotica is a clinical-stage biopharmaceutical company based in Cambridge, UK, founded in 2016.
Founded 2016Saffron Walden, United Kingdom$117Mlast round Sept 2026 - 48
Vor BiopharmaVor Biopharma is an immuno-oncology company that develops therapies for treating cancer.Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Founded 2016Cambridge, United States$117Mlast round Mar 2026 - 49
ApollomicsApollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Founded -Foster City, United States$116Mlast round Aug 2026 - 50
MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and development, particularly in oncology aMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and development, particularly in oncology a
Founded 2011Cambridge, United Kingdom$113Mlast round Oct 2025
Cambridge, United States
Saint Laurent, Canada
Shanghai, China
Basel, Switzerland
London, United Kingdom
Marseille, FranceCompanies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Who backed them?
Open any company for its rounds and investors, or search the investors who back oncology startups worldwide in the app, with filters, lists and exports.
More oncology lists
See allMore lists worldwide
See all
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830BGVVRPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94BOABAI startups that raised in 20262,922 companies · $540B in 2026FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
A
P
OMarketing tech startups worldwide2,728 companies · $28B